Today is Giving Tuesday. Support independent journalism by making a regular contribution to The New Humanitarian.

  1. Home
  2. Africa
  3. Southern Africa
  4. Angola

WHO move boosts fight against fatal diarrhoea

A young diarrhoea patient  in a Dhaka hospital.
(Shamsuddin Ahmed/IRIN)

The World Health Organization has paved the way for children in Africa and Asia to be vaccinated against a diarrhoea-causing virus that kills some 500,000 children annually worldwide – 85 percent of them in African and Asian developing countries.



WHO has recommended that the vaccine for rotavirus – the leading cause of severe and often fatal diarrhoea and dehydration in under-five children – be included in national immunization programmes worldwide.



As of 2007 the organization had said more research was needed on the vaccine’s efficacy in developing countries with high child mortality; new data from clinical trials has led WHO to recommend global use of the vaccine, according to a 5 June communiqué.



The decision means poor countries in Asia and Africa can now apply for funding to include rotavirus vaccines in their national immunization programmes.



“This [vaccine] will significantly reduce mortality and morbidity of rotavirus disease,” Samba Ousmane Sow, associate professor of medicine at University of Maryland and coordinator of the Centre for Vaccine Development in Mali, told IRIN.



“For rotavirus, as with many infectious diseases, mortality is often a question of geography,” he said. “For the many people in rural Africa who cannot easily access medical care, the best and most practical solution [against this lethal illness] is to bring the vaccine to them.”



A child with rotavirus disease – which causes fever, vomiting and diarrhoea – can rapidly become dehydrated. Death from rotavirus is most common where there is no quick access to medical care, so vaccination is the most effective way to prevent severe cases and deaths, experts say.



Transmitted primarily by the faecal-oral route, the virus affects the vast majority of children globally before age three, according to WHO. The virus attacks the villi – tiny projections on the wall of the small intestine. Destruction of the affected cells reduces digestion and absorption of nutrients, resulting in diarrhoea with a loss of fluids.



The virus is resilient and traditional hygiene measures that might prevent other sanitation-related illnesses are not sufficient to limit its impact, according to PATH, an international health non-profit and one of the organizations conducting vaccine trials with WHO and the Global Alliance for Vaccines and Immunization (GAVI).









''For rotavirus, as with many infectious diseases, mortality is often a question of geography''

But given that there are many causes of diarrhoeal disease, the rotavirus vaccine must be part of a comprehensive control strategy, including improving water quality, hygiene and sanitation and providing oral rehydration solution and zinc supplements, WHO says in its communiqué.



"This [oral] vaccine, coupled with improvement of sanitation and hygiene, can shrink the gamut of diarrhoeal diseases within a population," George Armah, professor and rotavirus expert at Ghana's Noguchi Memorial Insitute for Medical Research, told IRIN in the Senegalese capital Dakar, where he was attending a meeting of the West Africa rotavirus advisory group.



"But we know that hygiene alone does not eliminate the rotavirus, hence the urgent need for this vaccine."



Armah noted that now governments will have to prepare an investment plan for including rotavirus vaccine in their immunization programmes. The GAVI Alliance uses a co-financing approach, in which countries procure some vaccines with non-GAVI funds; the intention is for countries to gradually increase their share of vaccines' cost, making immunization programmes sustainable.



The GAVI Alliance board is expected to decide at its November 2009 meeting whether all 72 GAVI-eligible countries will now become eligible to apply for funding to include the rotavirus vaccine in their immunization programmes, GAVI’s Ariane Leroy told IRIN.



Clinical trials of the vaccine are ongoing in Asia and sub-Saharan Africa, but WHO’s Strategic Advisory Group of Experts has recommended the vaccine for all populations given available evidence, WHO says.



np/aj

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article
Join the discussion

Dear Reader,

Today is Giving Tuesday, a day of global giving back to the causes you care about. It’s a day when people around the world will be doing something to support the good causes they care about. As a reader of The New Humanitarian, we know that you care about quality journalism from the heart of crises. 

We broke so many important stories this year. But our work isn’t done. As we compile our annual Ten Crises and Trends to Watch list for 2022, we can see that there’s never been a greater need for independent journalism covering crises. 

We’ll be there, on the ground, reporting on issues like the economic fallout from the pandemic, youth unemployment and radicalisation, locally led peace efforts, and much more. It’s vital that we continue with our mission of putting quality, independent journalism at the service of the millions of people affected by humanitarian crises around the world.

But this work is expensive. Investigations can cost thousands of dollars. We can’t do what we do without the financial support of our donors and readers like you. This December, we’ll be launching a fundraising campaign so we can end the year in the strongest possible position, ready for 2022. You’ll hear about the campaign over email and on social media. 

But you can get in early and show your support today, on Giving Tuesday, by making a regular contribution to our work and becoming a member of The New Humanitarian

Please donate what you can.

Thank you.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join